Researchers continue to excited about the medication , a novel dual agonist showing remarkable results in early trials for size loss . It functions by modulating two systems: GLP-1 and GIP, these, when https://ronalddvqs766331.ssnblog.com/39466482/a-new-prospect-for-weight-loss